Business Context and Reporting Period
Company: Axcelis Technologies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2005
Business Overview: Axcelis is a worldwide producer of ion implantation, dry strip, thermal processing, and curing equipment for semiconductor fabrication. The company also provides aftermarket services and holds a 50% equity interest in Sumitomo Eaton Nova Corporation (SEN), a joint venture in Japan that manufactures and sells ion implantation products.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2005 |
Three Months Ended June 30, 2004 |
Six Months Ended June 30, 2005 |
Six Months Ended June 30, 2004 |
|---|---|---|---|---|
| Total Revenue | $92,178 | $151,348 | $192,214 | $285,573 |
| Gross Profit | $38,940 | $68,400 | $80,737 | $118,576 |
| Gross Margin % | 42.2% | 45.2% | 42.0% | 41.5% |
| Operating Income (Loss) | $(5,121) | $27,418 | $(4,655) | $38,851 |
| Net Income | $749 | $34,471 | $2,647 | $48,052 |
| Diluted EPS | $0.01 | $0.33 | $0.03 | $0.47 |
| Cash & Equivalents | $90,011 (as of June 30, 2005) Short-term Investments: $88,884 |
|||
| Long-term Debt |
Liquidity: Total cash, cash equivalents, and short-term investments were $178.9 million as of June 30, 2005. The company maintains a $50 million revolving credit facility expiring in 2006, with no outstanding borrowings at the reporting date.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 39% year-over-year for the quarter and 33% for the six-month period. System sales dropped significantly ($48.9M vs. $106.8M in Q2) due to declining demand for semiconductor equipment and reduced capacity expansion at 200mm facilities.
- Operating Loss: The company reported an operating loss of $5.1 million for the quarter, compared to an operating income of $27.4 million in the prior year. This was driven by lower revenue volume and increased operating expenses.
- Restructuring Charges: The company recorded $2.1 million in restructuring charges for the quarter (and $3.9 million for the six months) related to workforce reductions and the consolidation of operations from Rockville, Maryland, to Beverly, Massachusetts. This included a $0.6 million impairment charge for leasehold improvements.
- Equity Income: Equity income from the SEN joint venture remained stable at $7.6 million for the quarter but declined to $10.0 million for the six months (down from $13.1 million in 2004) due to demand fluctuations in the Japanese market.
- Product Mix: The proportion of revenue from 300mm products increased to 57% in Q2 2005 (from 28% in Q2 2004), reflecting a market shift away from 200mm facilities.
Guidance, Outlook, and Risks
- Q3 2005 Forecast: Management forecasts net revenues (excluding SEN) for the third quarter of 2005 to be in the range of $80.0 million to $90.0 million. Gross margins are projected in the low 40s, with a net loss of $0.06 to $0.10 per share.
- SEN Contribution: The contribution from the SEN joint venture is forecast to decrease significantly to approximately $2.0 million for the quarter due to volume fluctuations in Japan.
- Outlook: The company anticipates a slight decrease in revenues for the quarter ended September 30, 2005, compared to the second quarter, citing a slowdown in customer capital spending and order delays.
- Risks: Key risks include the cyclical nature of the semiconductor industry, dependence on SEN for the Japanese market, rapid technological changes, and the potential for quarterly fluctuations due to the timing of large orders.
- Accounting Changes: The company plans to adopt SFAS 123(R) regarding share-based payments effective January 1, 2006, which will require recognizing compensation costs for stock options in the income statement, potentially impacting future earnings.
Investor Verification Checklist
- Revenue Recognition Policy: Verify the application of EITF 00-21 and the residual method for allocating revenue in multi-element arrangements, particularly regarding deferred revenue ($45.7 million total).
- Restructuring Costs: Confirm the total expected cost of the Rockville consolidation ($11M-$12M) and the timing of remaining cash expenditures ($3M-$4M expected in H2 2005).
- SEN Joint Venture Performance: Monitor the volatility of equity income and royalties from SEN, which significantly impacts net income despite the company's 50% ownership and lack of control.
- Deferred Tax Assets: Note the full valuation allowance on deferred tax assets due to cumulative losses; assess the likelihood of future profitability to realize these benefits.
- Customer Concentration: Review the impact of top customers, as one customer accounted for 21% of Q2 2005 revenue and another for 10%.